Valet, G. Former Research Groups, Max Planck Institute of Biochemistry, Max Planck Society;
Owczarczyk, K., Passon, D., Roehrs, T., Jung, N., Taubert, D., Valet, G., et al. (2007). Circulating CD22+CD20-CD19+ cells at baseline may predict the clinical response to rituximab in patients with active RA. Zeitschrift fur Rheumatologie, 66(Suppl. Suppl. 1), 40-40.